Mark Oldakowski - 02 Feb 2026 Form 4 Insider Report for Bionano Genomics, Inc. (BNGO)

Role
CHIEF OPERATING OFFICER
Signature
/s/ Jonathan V. Dixon, Attorney-in-Fact
Issuer symbol
BNGO
Transactions as of
02 Feb 2026
Net transactions value
$0
Form type
4
Filing time
04 Feb 2026, 16:17:32 UTC
Previous filing
12 Sep 2025
Next filing
18 Feb 2026
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Mark Oldakowski filed Form 4 for Bionano Genomics, Inc. (BNGO) on 04 Feb 2026."

Quick Takeaways

  • This page summarizes Mark Oldakowski's Form 4 filing for Bionano Genomics, Inc. (BNGO).
  • 1 reported transaction and 1 derivative row are listed below.
  • Filing timestamp: 04 Feb 2026, 16:17.

What Changed

  • Previous filing in this sequence was filed on 12 Sep 2025.
  • Current net transaction value: $0.

Why This Matters

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Official SEC Source

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
OLDAKOWSKI MARK CHIEF OPERATING OFFICER C/O BIONANO GENOMICS, INC., 9540 TOWNE CENTRE DRIVE, SUITE 100, SAN DIEGO /s/ Jonathan V. Dixon, Attorney-in-Fact 04 Feb 2026 0001745566

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BNGO Stock Option (Right to Buy) Award $0 +27,737 $0.000000 27,737 02 Feb 2026 Common Stock 27,737 $1.27 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each option award vests as follows: the shares subject to the option vest monthly over 48 months beginning on the one-month anniversary of the vesting commencement date, such that the option shall be fully vested and exercisable on the four-year anniversary of the vesting commencement date.

Sponsored